Acute Tocolysis With Terbutaline for Suspected Fetal Distress

• Status: Completed
• Trial end date: 2019-09-15
• Target enrollment: 0
• Participant gender: Female

Summary

The trial was to determine the effect of administrating subcutaneous terbutaline prior to emergency caesarean delivery for suspected fetal distress

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Hospital Kemaman
• Treatments: Terbutaline

Criteria

Inclusion Criteria:

• term singleton pregnancy

• cephalic presentation

• in labour with cervix dilatation > 4cm and regular uterine contractions of 3 or more 10 min

• abnormal fetal heart rate status diagnosed using standard electronic FHR according to NICE guideline (2014)

• acceptance of participation by the signing of a written consent.

Exclusion Criteria

• maternal cardiopathy

• hyperthyroidism

• abruptio placentae or other placental accidents

• hypertensive disease of pregnancy

• hyperstimulation with oxytocin

• multiple gestation

• abnormal fetus planned for conservative management

• evidence of intrauterine growth restriction

• patient on medication which will interact with terbutaline (tricyclic antidepressants, beta-blockers, diuretics and sympathomimetic medicine).